Certificación serológica de la interrupción de la transmisión vectorial de la enfermedad de Chagas en Chile

Background: In 1999 an International Commission of Experts evaluated the sanitary interventions that started in 1980 to eliminate Triatoma infestans, the biological vector of Chagas disease, to certify if the conditions needed to interrupt the transmission, were achieved. Aim: To report the data use...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lorca H,Myriam, García C,Alejandro, Bahamonde M,María Inés, Fritz M,Annelise, Tassara O,Renzo
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2001
Materias:	Chagas disease Triatoma Trypanosoma cruzi
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000300005
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872001000300005
record_format	dspace
spelling	oai:scielo:S0034-988720010003000052001-05-22Certificación serológica de la interrupción de la transmisión vectorial de la enfermedad de Chagas en ChileLorca H,MyriamGarcía C,AlejandroBahamonde M,María InésFritz M,AnneliseTassara O,Renzo Chagas disease Triatoma Trypanosoma cruzi Background: In 1999 an International Commission of Experts evaluated the sanitary interventions that started in 1980 to eliminate Triatoma infestans, the biological vector of Chagas disease, to certify if the conditions needed to interrupt the transmission, were achieved. Aim: To report the data used by the International certification commission to certify the interruption of vectorial transmission of Chagas disease in Chile. Material and methods: A comparative evaluation of the prevalence of Trypanosoma cruzi antibodies in children surveyed between 1994 and 1995 and between 1995 and 1999. Results: In the first period, 5.948 children were surveyed and in the second, 5.069 children were studied. Twenty children (0.4%) were positive for Trypanosoma cruzi antibodies in the second survey. These figures were significantly lower than the 1.1% prevalence detected between 1994 and 1995. In only three of the 20 cases, the transmission through vectors was confirmed, which represents a 99.4% reduction of this way of transmission. Conclusions: Based on these findings, the Commission certified that Chile is the second country in Latin America to interrupt the vector transmission of Chagas disease. The successful public health program for Chagas disease will have a positive impact improving the quality of life of rural populations, that are most exposed to the disease. (Rev Méd Chile 2001; 129: 264-9).info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.129 n.3 20012001-03-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000300005es10.4067/S0034-98872001000300005
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Chagas disease Triatoma Trypanosoma cruzi
spellingShingle	Chagas disease Triatoma Trypanosoma cruzi Lorca H,Myriam García C,Alejandro Bahamonde M,María Inés Fritz M,Annelise Tassara O,Renzo Certificación serológica de la interrupción de la transmisión vectorial de la enfermedad de Chagas en Chile
description	Background: In 1999 an International Commission of Experts evaluated the sanitary interventions that started in 1980 to eliminate Triatoma infestans, the biological vector of Chagas disease, to certify if the conditions needed to interrupt the transmission, were achieved. Aim: To report the data used by the International certification commission to certify the interruption of vectorial transmission of Chagas disease in Chile. Material and methods: A comparative evaluation of the prevalence of Trypanosoma cruzi antibodies in children surveyed between 1994 and 1995 and between 1995 and 1999. Results: In the first period, 5.948 children were surveyed and in the second, 5.069 children were studied. Twenty children (0.4%) were positive for Trypanosoma cruzi antibodies in the second survey. These figures were significantly lower than the 1.1% prevalence detected between 1994 and 1995. In only three of the 20 cases, the transmission through vectors was confirmed, which represents a 99.4% reduction of this way of transmission. Conclusions: Based on these findings, the Commission certified that Chile is the second country in Latin America to interrupt the vector transmission of Chagas disease. The successful public health program for Chagas disease will have a positive impact improving the quality of life of rural populations, that are most exposed to the disease. (Rev Méd Chile 2001; 129: 264-9).
author	Lorca H,Myriam García C,Alejandro Bahamonde M,María Inés Fritz M,Annelise Tassara O,Renzo
author_facet	Lorca H,Myriam García C,Alejandro Bahamonde M,María Inés Fritz M,Annelise Tassara O,Renzo
author_sort	Lorca H,Myriam
title	Certificación serológica de la interrupción de la transmisión vectorial de la enfermedad de Chagas en Chile
title_short	Certificación serológica de la interrupción de la transmisión vectorial de la enfermedad de Chagas en Chile
title_full	Certificación serológica de la interrupción de la transmisión vectorial de la enfermedad de Chagas en Chile
title_fullStr	Certificación serológica de la interrupción de la transmisión vectorial de la enfermedad de Chagas en Chile
title_full_unstemmed	Certificación serológica de la interrupción de la transmisión vectorial de la enfermedad de Chagas en Chile
title_sort	certificación serológica de la interrupción de la transmisión vectorial de la enfermedad de chagas en chile
publisher	Sociedad Médica de Santiago
publishDate	2001
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000300005
work_keys_str_mv	AT lorcahmyriam certificacionserologicadelainterrupciondelatransmisionvectorialdelaenfermedaddechagasenchile AT garciacalejandro certificacionserologicadelainterrupciondelatransmisionvectorialdelaenfermedaddechagasenchile AT bahamondemmariaines certificacionserologicadelainterrupciondelatransmisionvectorialdelaenfermedaddechagasenchile AT fritzmannelise certificacionserologicadelainterrupciondelatransmisionvectorialdelaenfermedaddechagasenchile AT tassaraorenzo certificacionserologicadelainterrupciondelatransmisionvectorialdelaenfermedaddechagasenchile
_version_	1718435961209094144

Certificación serológica de la interrupción de la transmisión vectorial de la enfermedad de Chagas en Chile

Ejemplares similares